November 2013 FDA Recall Travasol by Baxter Healthcare Corp.
D-368-2014 - Lack of Assurance of Sterility; Drug product leaking from container therefore sterility cannot be assured

This Class II drug recall was voluntarily initiated by Baxter Healthcare Corp. on November 12, 2013 for the product Travasol. The FDA reported the reason for recall as lack of assurance of sterility; drug product leaking from container therefore sterility cannot be assured. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-368-2014

Reason for Recall
Lack of Assurance of Sterility; Drug product leaking from container therefore sterility cannot be assured
Initiated
11-12-2013
Reported
12-25-2013
Quantity
14,622 bags

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Baxter Healthcare Corp.
10%, Travasol (Amino Acid) Injection, 2000 ml, Pharmacy Bulk Package Not for Direct Infusion, Baxter Healthcare Corporation, Clintec Nutrition Division, Deerfield IL 60015 USA. NDC: 0338-0644-06.

Batch or Lot Expiration Information

Lot# Lot: P302646, Exp 5/31/15